Cerebral microembolism, a disease marker for ischemic cerebrovascular events in the antiphospholipid syndrome of systemic lupus erythematosus?

Acta Neurologica Scandinavica

Volumn 99, Issue 6, 1999, Pages 356-361

  Rademacher, Jörg ^a   Sohngen D ^a   Specker, C ^a   Janda, I ^a   Sitzer, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antibodies; Antiphospholipid; Embolism; Heart disease; Lupus erythematosus; Ultrasonics

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN EMBOLISM; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MICROEMBOLISM; PATIENT MONITORING; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032982221     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1999.tb07364.x     Document Type: Article

References (30)

1. 1. ASHERSON RA, KHAMASHTA MA, GIL A et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989;86:391-9.
2. 2. LOVE PE, SANTORO SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990;112:682-98.
3. 3. TOSCHI V, MOTTA A, CASTELLI C et al. Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosus. Haemostasis 1993;23:275-83.
4. 4. SÖHNGEN D, WEHMEIER A, SPECKER C, SCHNEIDER W. Antiphospholipid antibodies in systemic lupus erythematosus and Sneddon's syndrome. Sem Thromb Haemost 1994;20(1):55-63.
5. 5. HARRIS EN, CHAN JKH, ASHERSON RA, ABER VR, GHARAVI AE, HUGHES GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia. Arch Intern Med 1986;146:2153-6.
6. 6. ALARCÓN-SEGOVIA D, DELEZÉ M, ORIA CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. Medicine 1989;68:353-65.
7. 7. LEVINE SR, DEEGAN MJ, FUTRELL N, WELCH KM. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies. 48 cases. Neurology 1990;40:1181-9.
8. 8. EUSTACE S, HUTCHINSON M, BRESNIHAN B. Acute cerebrovascular episodes in systemic lupus erythematosus. Q J Med 1991;81:739-50.
9. 9. DEVINSKY O, PETITO CK, ALONSO DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombocytopenic purpura. Ann Neurol 1988;23:380-4.
10. 10. BICK RL, BAKER WF. Antiphospholipid and thrombosis syndromes. Sem Thromb Haemost 1994;20(1):3-15.
11. 11. ROSOVE MH, BREWER PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303-8.
12. 12. VIANNA JL, KHAMASHTA MA, ORDI-ROS J. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 1994;96:3-9.
13. 13. FRIES JF, HOCHBERG MC, MEDSGER TA Jr, HUNDER GG, BOMBARDIER C, and the American College of Rheumatology/Diagnostic and Therapeutic Criteria Committee. Criteria for rheumatic disease. Different types and different functions. Arthritis Rheum 1994;37:454-62.
14. 14. SPENCER MP, THOMAS GI, NICHOLLS SC, SAUVAGE LR. Detection of middle cerebral artery emboli during carotid artery endarterectomy using transcranial Doppler ultra-sonography. Stroke 1990;21:415-23.
15. 15. SIEBLER M, SITZER M, STEINMETZ H. Detection of intracranial emboli in patients with symptomatic extracranial carotid artery disease. Stroke 1992;23:1652-4.
16. 16. BABIKIAN VL, HYDE C, POCHAY V, WINTER MR. Clinical correlates of high-intensity transient signals detected on transcranial Doppler sonography in patients with cerebrovascular disease. Stroke 1994;25:1570-3.
17. 17. RIES S, SCHMINKE U, DAFFERTSHOFER M, SCHINDLMAYR C, HENNERICI M. High intensity transcranial signals in carotid artery disease. Cerebrovasc Dis 1995;5:124-7.
18. 18. SIEBLER M, NACHTMANN A, SITZER M et al. Cerebral microembolism and the risk of ischemia in asymptomatic high-grade internal carotid artery stenosis. Stroke 1995;26:2184-6.
19. 19. SITZER M, SÖHNGEN D, SIEBLER M et al. Cerebral microembolism in patients with Sneddon's syndrome. Arch Neurol 1995;52:271-5.
20. 20. SPECKER Ch, RADEMACHER J, SÖHNGEN D et al. Cerebral microemboli in patients with antiphospholipid syndrome. Lupus 1997;6:638-14.
21. 21. TAN EM, COHEN AS, FRIES JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
22. 22. TRIPLETT DA. Coagulation assays for the lupus anticoagulant: review and critique of current methodology. Stroke 1992;23(suppl I):11-14.
23. 23. EXNER T, RICKARD KA, KRONENBERG H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978;40:143-51.
24. 24. SOHNGEN D, SPECKER C, WEHMEIER A et al. Prävalenz von Lupusantikoagulans, Autoimmunhämolyse, Thrombozytopenie und Plättchenfunktionsstörungen bei unselektionierten Patienten mit SLE. Transfusionsmedizin 1992;30:469-73.
25. 25. HARRIS EN. The Second International Anti-cardiolipin Standardization Workshop/ the Kingston Antiphospholipid Antibody Study (KAPS) Group. Am J Clin Pathol 1990;94:476-84.
26. 26. RINGELSTEIN EB, DROSTE DW, BABIKIAN VL et al. Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke 1998;29:725-9.
27. 27. MARKUS H, BLAND JM, ROSE G, SITZER M, SIEBLER M. How good is intercenter agreement in the identification of embolic signals in carotid artery disease? Stroke 1996;27:1249-52.
28. 28. KHAMASHTA MA, VAZQUEZ JJ, PARE C, INGELMO M, OLIVER J, HUGHES GRV. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990;335:1541-4.
29. 29. GALVE E, ORDI J, BARQUINERO J, EVANGELISTA A, VILARDELL M, SOLER-SOLER J. Valvular heart disease in the primary antiphospholipid syndrome. Ann Intern Med 1992;116:293-8.
30. 30. Cerebral Embolism Task Force. Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. Arch Neurol 1989;46:727-43.